...
【24h】

Feature selection and syndrome prediction for liver cirrhosis in traditional Chinese medicine.

机译:中医肝硬化的特征选择和证候预测。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Traditional Chinese medicine (TCM) treatment is one of the safe and effective methods for liver cirrhosis. In the process of its treatment, a very important step, syndrome prediction is generally performed by physicians at present, which actually hinders the application prospects of TCM. Based on the data mining algorithm, a novel method called TCMSP (traditional Chinese medicine syndrome prediction) is proposed, which consists of two phases. In the first phase, based on an improved information gain method in multi-view, the critical features are filtered from the original features. In the second phase, the class label of a new case is predicted automatically based on accuracy-weighted majority voting. The proposed method is evaluated by the liver cirrhosis dataset, 20 critical features are selected from original 105 features and the corresponding syndromes of 138 new cases are identified respectively. The critical features are in sound agreement with those used by the physicians in making their clinical decisions. Finally, this new method is also demonstrated on three standard datasets (SPECT Heart, Lung Cancer and Iris) and the results are compared with some other methods. The experimental results show that TCMSP method performs well in the field of TCM diagnosis.
机译:中医治疗肝硬化是安全有效的方法之一。在其治疗过程中,非常重要的一步,目前通常由医师进行证候预测,这实际上阻碍了中医的应用前景。基于数据挖掘算法,提出了一种由两个阶段组成的新方法TCMSP(中医证候预测)。在第一阶段,基于改进的多视图信息获取方法,从原始特征中筛选出关键特征。在第二阶段,将基于准确性加权多数表决自动预测新案件的类别标签。通过肝硬化数据集对提出的方法进行评估,从原始的105个特征中选择20个关键特征,并分别识别138例新病例的相应证候。关键特征与医师在做出临床决定时所使用的特征完全一致。最后,该新方法还在三个标准数据集(SPECT心脏,肺癌和虹膜)上得到了证明,并将结果与​​其他一些方法进行了比较。实验结果表明,TCMSP方法在中医诊断领域表现良好。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号